Roger Olofsson Bagge

Professor/ Chief Physician

Department of
Visiting address
Blå stråket 5, vån 3 SU/Sahlgrenska
41345 Göteborg
Postal address
Sahlgrenska Universitetssjukhuset
41345 Göteborg

About Roger Olofsson Bagge

Gothenburg University's film about Roger's research in connection with his installation as a professor at the department of clinical sciences (1:30)

Roger Olofsson Bagge is a Professor in Cancer Surgery at the Institute of Clinical Sciences at Sahlgrenska Academy. He is also a Senior consultant surgeonat the Sahlgrenska University Hospital.

He has a research group including both clinical and pre-clinical research within Wallenberg Centre of Molecular and Translational Medicine where the focus is translational cancer research, mainly concerning malignant melanoma and breast cancer. Link to Rogers Olofsson Bagges research group

Examples of ongoing projects

  1. ExoBioMark - Translational biomarker study including patients with breast cancer and melanoma
  2. SCANDIUM - A phase III randomized controlled trial evaluating isolated hepatic perfusion (IHP) vs. Best alternative care (BAC) (NCT01785316).
  3. SCANDIUM II - A phase I randomized controlled trial evaluating isolated hepatic perfusion (IHP) and immunotherapy using ipilimumab and nivolumab.
  4. MI-ILP - Minimally-invasive isolated limb perfusion (NCT03376126).
  5. Nivo-ILP - Double blind randomized controlled phase Ib/II trial evaluating the effect of adding nivolumab to isolated limb perfusion (NCT03685890).
  6. SUMMIST - Randomized controlled phase II trial evaluating the effect of metastasectomies in patients with stable disease or partial response after treatment with PD-1 inhibition (NCT04242329).
  7. MAGMEN - Identification and prediction of sentinel node status in melanoma using supraparamagnetic iron oxide nanoparticles and MRI (NCT03898687).

Pressrelease 230321 Effective treatment in rare but deadly form of cancer

Finalized PhD-projects

I have been the main supervisor for the following PhD thesis projects:

  1. Dr Valerio Belgrano, University of Gothenburg, thesis presented 2019-06-04 Development of individualized surgical treatments for malignant melanoma
  2. Dr Jenny Heiman, University of Gothenburg, thesis presented 2021-12-1 Breast cancer surgery – Aspects of patient-reported outcomes and physical activity

I have been assistant supervisor for the following PhD thesis projects:

  1. Iva Johansson, Gothenburg University, thesis presented 2022-12-14 Studies of molecular features and novel prognostic biomarkers of cutaneous melanoma
  2. Susanne Ahlstedt Karlsson, Gothenburg University, thesis presented 2022-05-25 Designing, developing, and evaluating a person-centered support model for women with breast cancer treated with endocrine therapy
  3. Elin Forsberg, University of Gothenburg, thesis presented 2020-01-10 Novel immunotherapies for metastatic melanoma - from mouse models towards clinical trials
  4. Junko Johansson, University of Gothenburg, thesis presented 2019-05-29 Immunological effects of isolated regional perfusion in malignant melanoma

Ongoing PhD-projects

I am currently supervisor for the following PhD thesis projects

Main supervisor:

  1. Anna Corderfeldt, Gothenburg University, Halftime seminar 2021-09-06
  2. Carl Jacob Holmberg, Gothenburg University, Halftime seminar planned 2022-05-11
  3. Nushin Mirzaei, Gothenburg University
  4. Lida Pistioli, Gothenburg University

Assistant supervisor:

  1. Slavica Janeva, Gothenburg University, Halftime seminar 2021-09-30
  2. Kian Chin, Gothenburg University
  3. Anna Arheden, Gothenburg University
  4. Pontus Zaar, Gothenburg University
  5. Michail Zoulakis, Gothenburg University

Major research funding

  • Swedish Research Council (Vetenskapsrådet)
  • American Association for Cancer Research (AACR)
  • Swedish Cancer Society (Cancerfonden)
  • Wallenberg Foundation
  • Region Västra Götaland
  • Assar Gabrielsson foundation
  • Gothenburg Medical Association
  • Swedish state (ALF-agreement)
  • Gothenburg research council

Received grants and prizes - 2021 and forwards